Immunovant, Inc. (IMVT) Reports In-Line Q2 EPS
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.45), in-line with the analyst estimate of ($0.45).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.45), in-line with the analyst estimate of ($0.45).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.